8a, 9-dihydro-4a-H-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents

Details for Australian Patent Application No. 2005331275 (hide)

Owner Achillion Pharmaceuticals, Inc.

Inventors Deshpande, Milind; Wang, Qiuping; Bradbury, Barton James; Lucien, Edlaine; Hashimoto, Akihiro; Pucci, Michael John; Song, Yongsheng; Wiles, Jason Allan

Agent Cullen & Co

Pub. Number AU-A-2005331275

PCT Pub. Number WO2006/118605

Priority 60/626,961 11.11.04 US

Filing date 10 November 2005

Wipo publication date 9 November 2006

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/437 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 (2006.01) Antiparasitic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/118605 Priority application(s): WO2006/118605

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005331278-Therapeutic micro-vibration device

2005331265-Nanostructured thin films and their uses